Nektar Therapeutics (NKTR)
69.97
-0.80 (1.13%)
Upcoming Events
Latest Headlines
Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
July 28, 2026 6:00 PM - PR NewsWire
Form 4 NEKTAR THERAPEUTICS For: Jul 24 Filed by: Zalevsky Jonathan
July 24, 2026 6:35 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: Jul 24 Filed by: ROBIN HOWARD W
July 24, 2026 6:35 PM - SEC Filing
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 24, 2026 4:15 PM - PR NewsWire
Canaccord Starts Nektar Therapeutics (NKTR) at Buy
July 22, 2026 5:52 AM - StreetInsider
Nektar starts Phase 3 trials for eczema drug rezpegaldesleukin
July 21, 2026 7:00 AM - StreetInsider
Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
July 21, 2026 7:00 AM - PR NewsWire
Form 4 NEKTAR THERAPEUTICS For: Jun 30 Filed by: Zalevsky Jonathan
July 2, 2026 7:07 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan
June 30, 2026 4:36 PM - SEC Filing
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 26, 2026 4:30 PM - PR NewsWire
Form 4 NEKTAR THERAPEUTICS For: Jun 16 Filed by: ROBIN HOWARD W
June 18, 2026 7:08 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: Jun 15 Filed by: Zalevsky Jonathan
June 17, 2026 7:13 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
June 17, 2026 11:06 AM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
June 16, 2026 11:07 AM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan
June 15, 2026 4:57 PM - SEC Filing
Form 8-K NEKTAR THERAPEUTICS For: Jun 05
June 5, 2026 4:31 PM - SEC Filing
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 3, 2026 4:15 PM - PR NewsWire
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
May 27, 2026 6:16 PM - PR NewsWire
Form 3 NEKTAR THERAPEUTICS For: May 15 Filed by: Rubinstein Linda M
May 26, 2026 6:20 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: May 19 Filed by: Zalevsky Jonathan
May 21, 2026 6:27 PM - SEC Filing
Form 4 NEKTAR THERAPEUTICS For: May 19 Filed by: ROBIN HOWARD W
May 21, 2026 6:26 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: Zalevsky Jonathan
May 19, 2026 3:28 PM - SEC Filing
Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W
May 19, 2026 3:25 PM - SEC Filing
Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: BIOTECHNOLOGY VALUE FUND L P
May 15, 2026 4:19 PM - SEC Filing
Form 424B5 NEKTAR THERAPEUTICS
May 8, 2026 5:23 PM - SEC Filing
Form 8-K NEKTAR THERAPEUTICS For: May 08
May 8, 2026 5:11 PM - SEC Filing
Nektar Therapeutics (NKTR ) PT Raised to $192 at Piper Sandler
May 8, 2026 7:58 AM - StreetInsider
Form 10-Q NEKTAR THERAPEUTICS For: Mar 31
May 8, 2026 6:03 AM - SEC Filing
Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
May 7, 2026 4:38 PM - StreetInsider
Form 8-K NEKTAR THERAPEUTICS For: May 07
May 7, 2026 4:33 PM - SEC Filing
Nektar Therapeutics Reports First Quarter 2026 Financial Results
May 7, 2026 4:15 PM - PR NewsWire
Form SCHEDULE 13G/A NEKTAR THERAPEUTICS Filed by: FMR LLC
May 6, 2026 11:31 AM - SEC Filing
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026 4:40 PM - PR NewsWire
Full Article List
